Verastem, Inc. (VSTM) stock
VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.87−0.54 (-7.29%)
Close on Nov 18, 2026Market cap $622.17MP/E –Yield –
Verastem operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Verastem's operating income for the twelve months ending Jun 30, 2026 was -$159.80M. For fiscal 2025 it was -$170.13M. The highest annual figure on record is -$13.70M in fiscal 2011.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$170.13M | – |
| FY2024 | Dec 31, 2024 | -$114.96M | – |
| FY2023 | Dec 31, 2023 | -$92.08M | – |
| FY2022 | Dec 31, 2022 | -$72.94M | – |
| FY2021 | Dec 31, 2021 | -$61.41M | – |
| FY2020 | Dec 31, 2020 | -$49.36M | – |
| FY2019 | Dec 31, 2019 | -$132.34M | – |
| FY2018 | Dec 31, 2018 | -$94.78M | – |
| FY2017 | Dec 31, 2017 | -$67.80M | – |
| FY2016 | Dec 31, 2016 | -$37.00M | – |
| FY2015 | Dec 31, 2015 | -$58.20M | – |
| FY2014 | Dec 31, 2014 | -$53.61M | – |
| FY2013 | Dec 31, 2013 | -$41.40M | – |
| FY2012 | Dec 31, 2012 | -$32.23M | – |
| FY2011 | Dec 31, 2011 | -$13.70M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$32.71M | – |
| Q1 FY2026 | Mar 31, 2026 | -$44.90M | – |
| Q4 FY2025 | Dec 31, 2025 | -$41.48M | – |
| Q3 FY2025 | Sep 30, 2025 | -$40.72M | – |
| Q2 FY2025 | Jun 30, 2025 | -$43.76M | – |
| Q1 FY2025 | Mar 31, 2025 | -$44.17M | – |
| Q4 FY2024 | Dec 31, 2024 | -$31.59M | – |
| Q1 FY2024 | Jun 30, 2024 | -$46.34M | – |
| Q4 FY2023 | Dec 31, 2023 | -$31.14M | – |
| Q3 FY2023 | Sep 30, 2023 | -$21.31M | – |
| Q2 FY2023 | Jun 30, 2023 | -$20.29M | – |
| Q1 FY2023 | Mar 31, 2023 | -$19.34M | – |
| Q4 FY2022 | Dec 31, 2022 | -$16.85M | – |
| Q3 FY2022 | Sep 30, 2022 | -$17.71M | – |
| Q2 FY2022 | Jun 30, 2022 | -$21.40M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.98M | – |
| Q4 FY2021 | Dec 31, 2021 | -$16.51M | – |
| Q3 FY2021 | Sep 30, 2021 | -$14.85M | -198.9% |
| Q2 FY2021 | Jun 30, 2021 | -$15.94M | – |
| Q1 FY2021 | Mar 31, 2021 | -$14.11M | – |
| Q4 FY2020 | Dec 31, 2020 | -$16.75M | – |
| Q3 FY2020 | Sep 30, 2020 | $15.02M | – |
| Q2 FY2020 | Jun 30, 2020 | -$21.26M | – |
| Q1 FY2020 | Mar 31, 2020 | -$26.36M | – |
| Q4 FY2019 | Dec 31, 2019 | -$33.29M | – |
| Q3 FY2019 | Sep 30, 2019 | -$26.10M | – |
| Q2 FY2019 | Jun 30, 2019 | -$38.28M | – |
| Q1 FY2019 | Mar 31, 2019 | -$34.67M | – |
| Q4 FY2018 | Dec 31, 2018 | -$34.26M | – |
| Q3 FY2018 | Sep 30, 2018 | -$21.57M | – |
| Q2 FY2018 | Jun 30, 2018 | -$18.19M | – |
| Q1 FY2018 | Mar 31, 2018 | -$20.76M | – |
| Q4 FY2017 | Dec 31, 2017 | -$18.05M | – |
| Q3 FY2017 | Sep 30, 2017 | -$23.14M | – |
| Q2 FY2017 | Jun 30, 2017 | -$13.47M | – |
| Q1 FY2017 | Mar 31, 2017 | -$13.15M | – |
| Q4 FY2016 | Dec 31, 2016 | -$11.80M | – |
| Q3 FY2016 | Sep 30, 2016 | -$8.06M | – |
| Q2 FY2016 | Jun 30, 2016 | -$8.71M | – |
See a number that looks wrong?